We are live on ! Find out more
NVO

Novo Nordisk
NVO

902 hedge funds and large institutions have $15.2B invested in Novo Nordisk in 2022 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 299 increasing their positions, 304 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 84 | Existing positions closed: 61

32% more call options, than puts

Call options by funds: $186M | Put options by funds: $141M

2% more funds holding

Funds holding: 886 → 902 (+16)

3% more capital invested

Capital invested by funds: $14.7B → $15.2B (+$496M)

0.69% more ownership

Funds ownership: 14.87% → 15.56% (+0.69%)

0% more funds holding in top 10

Funds holding in top 10: 23 → 23 (0)

2% less repeat investments, than reductions

Existing positions increased: 299 | Existing positions reduced: 304

Holders
902
Holders Change
+16
Holders Change %
+1.81%
% of All Funds
14.23%
Holding in Top 10
23
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.36%
New
84
Increased
299
Reduced
304
Closed
61
Calls
$186M
Puts
$141M
Net Calls
+$45M
Net Calls Change
-$44M

Top Buyers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
+$499M
2
BlackRock
BlackRock
New York
+$161M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$60M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$56.1M
5
VIP
Vantage Investment Partners
Missouri
+$50.2M

Top Sellers

Rank Fund Capital Flow
1
F
Folketrygdfondet
Norway
-$405M
2
ClearBridge Investments
ClearBridge Investments
New York
-$142M
3
Renaissance Technologies
Renaissance Technologies
New York
-$75.2M
4
Capital International Investors
Capital International Investors
California
-$33.6M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$29.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
SFM
951
Signet Financial Management
New Jersey
– -$31K -550 Closed
CA
952
Cornerstone Advisory
Maryland
– -$28K -500 Closed
TCWM
953
Total Clarity Wealth Management
Illinois
– -$23K -408 Closed
EWM
954
Edge Wealth Management
New York
– -$17K -300 Closed
NC
955
NewSquare Capital
Pennsylvania
– -$13K -236 Closed
TCM
956
TD Capital Management
Tennessee
– -$11K -202 Closed
HFS
957
Horizon Financial Services
North Carolina
– -$9.52K -170 Closed
RWA
958
RGT Wealth Advisors
Texas
– -$6K -114 Closed
EBA
959
Eagle Bay Advisors
New York
– -$3K -50 Closed
ACM
960
Absolute Capital Management
Pennsylvania
– -$2.69K -48 Closed
MP
961
McDonald Partners
Ohio
– -$2.69K -48 Closed
KFP
962
KB Financial Partners
New Jersey
– -$2K -44 Closed
BA
963
Bivin & Associates
Oklahoma
– -$1K -10 Closed
35 36 37 38
39

NVO Hedge Fund Activity: Q1 2022 in Review

902 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2022, worth a combined $15.2B — up 3.4% from $14.7B a quarter earlier.

Buyers outnumbered sellers: 84 funds opened new NVO positions and 61 closed out — a net gain of 23 holders — while 299 added to existing stakes and 304 trimmed.

The largest buyer was Jennison Associates, adding an estimated $499M. The largest seller was Folketrygdfondet, cutting an estimated $405M.

  • 902 institutional investors held Novo Nordisk (NVO) as of Q1 2022, up from 886 in Q4 2021.
  • Funds reported $15.2B of Novo Nordisk stock for Q1 2022, up 3.4% quarter-over-quarter.
  • 84 funds opened new Novo Nordisk positions in Q1 2022 and 61 closed out, a net change of +23 holders.
  • The largest Novo Nordisk buyer in Q1 2022 was Jennison Associates, an estimated $499M added.
  • The largest Novo Nordisk seller in Q1 2022 was Folketrygdfondet, an estimated $405M sold.

Based on aggregated 13F filings for Q1 2022.